Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study.
Cil I, Kucukarda A, Atcı MM, Secmeler S, Paksoy N, Ferhatoglu F, Ak N, Ayhan M, Tataroglu Ozyukseler D, Onder AH, Avci O, Oyman A, Okten IN, Gulturk I, Akagunduz B, Basoglu T, Cakir E, Hacibekiroglu I, Ozcelik M, Aydiner A. Cil I, et al. Among authors: gulturk i. Tumori. 2022 Feb;108(1):19-25. doi: 10.1177/03008916211037739. Epub 2021 Aug 7. Tumori. 2022. PMID: 34365852
Ribociclib induced acute kidney injury: A case report.
Gulturk I, Yilmaz M, Ozmen A, Tacar SY, Erdal GS, Tural D. Gulturk I, et al. J Oncol Pharm Pract. 2021 Dec;27(8):2023-2026. doi: 10.1177/10781552211007202. Epub 2021 Apr 13. J Oncol Pharm Pract. 2021. PMID: 33847193
Nivolumab induced hypophysitis in an advanced RCC patient.
Korkmaz Yilmaz M, Gulturk I, Tacar SY, Yilmaz M. Korkmaz Yilmaz M, et al. Among authors: gulturk i. J Oncol Pharm Pract. 2022 Apr;28(3):759-762. doi: 10.1177/10781552211072212. Epub 2022 Jan 10. J Oncol Pharm Pract. 2022. PMID: 35006033
Lutetium-Associated Myopathy: A Case Report.
Gulturk I, Sonmezoz GB, Yilmaz M, Tacar SY, Ozmen A, Erdal GS, Nalbant MO, Tural D. Gulturk I, et al. Am J Ther. 2024 Jan-Feb 01;31(1):e81-e84. doi: 10.1097/MJT.0000000000001491. Epub 2022 Mar 24. Am J Ther. 2024. PMID: 35383588 No abstract available.
Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes.
Ozbay MF, Harputluoglu H, Karaca M, Tekin O, Şendur MAN, Kaplan MA, Sahin B, Geredeli C, Teker F, Tural D, Saglam S, Çil T, Bilici A, Erol C, Kalkan Z, Bayram E, Selvi O, Gültürk İ, Göksu SS, Tatlı AM. Ozbay MF, et al. Among authors: gulturk i. Cancers (Basel). 2024 Nov 20;16(22):3880. doi: 10.3390/cancers16223880. Cancers (Basel). 2024. PMID: 39594835 Free PMC article.
17 results